Zafar Rasheed1, Tariq M Haqqi. 1. Department of Medicine, Division of Rheumatology, MetroHealth Medical Center, Cleveland, OH 44109, United States. zafarrasheed@rocketmail.com
Abstract
INTRODUCTION: During aging, advanced glycation end products (AGEs) accumulate in articular cartilage. In this study we determined whether AGEs induce endoplasmic reticulum (ER) stress and studied the ER stress-activated pathways that stimulate cyclooxygenase-2 (COX-2) expression in human chondrocytes. METHODS: Chondrocytes were stimulated with AGE-BSA. Gene expression was determined by quantitative PCR and protein expression was studied by immunoblotting. Studies to elucidate involved pathways were executed using siRNAs and specific inhibitors of eukaryotic initiation factor-2α (eIF2α), MAPKs and NF-κB. RESULTS: AGE-BSA induced expression of GRP78 with concomitant increase in COX-2 expression was observed in human chondrocytes. In addition, expression of Bag-1, an ER stress marker was also increased by AGE-BSA. RAGE knockdown inhibited AGE-BSA-induced expression of GRP78 and COX-2. Treatment with eIF2α inhibitor or eIF2α knockdown inhibited AGE-BSA-induced expression of GRP78 and COX-2 with decreased PGE(2) production. Treatment with SB202190 inhibited AGE-BSA-induced expression of GRP78 and COX-2, while treatment with PD98051 inhibited AGE-BSA-induced GRP78 protein expression but had no effect on COX-2 protein expression. SP600125 had no effect on either GRP78 or COX-2 protein expression. Bay 11-7082 suppressed AGE-BSA-induced GRP78 and COX-2 expression. AGE-BSA-induced activation of NF-κB was inhibited by treatment with SB202190 and by eIF2α knockdown, but was not inhibited when chondrocytes were treated with SP600125 or PD98059. CONCLUSION: This study demonstrates that AGEs induce ER stress and stimulate the expression of COX-2 through eIF2α, p38-MAPK and NF-κB pathways in human chondrocytes. Our results provide important insights into cartilage degradation in osteoarthritis associated with latent ER stress.
INTRODUCTION: During aging, advanced glycation end products (AGEs) accumulate in articular cartilage. In this study we determined whether AGEs induce endoplasmic reticulum (ER) stress and studied the ER stress-activated pathways that stimulate cyclooxygenase-2 (COX-2) expression in human chondrocytes. METHODS: Chondrocytes were stimulated with AGE-BSA. Gene expression was determined by quantitative PCR and protein expression was studied by immunoblotting. Studies to elucidate involved pathways were executed using siRNAs and specific inhibitors of eukaryotic initiation factor-2α (eIF2α), MAPKs and NF-κB. RESULTS: AGE-BSA induced expression of GRP78 with concomitant increase in COX-2 expression was observed in human chondrocytes. In addition, expression of Bag-1, an ER stress marker was also increased by AGE-BSA. RAGE knockdown inhibited AGE-BSA-induced expression of GRP78 and COX-2. Treatment with eIF2α inhibitor or eIF2α knockdown inhibited AGE-BSA-induced expression of GRP78 and COX-2 with decreased PGE(2) production. Treatment with SB202190 inhibited AGE-BSA-induced expression of GRP78 and COX-2, while treatment with PD98051 inhibited AGE-BSA-induced GRP78 protein expression but had no effect on COX-2 protein expression. SP600125 had no effect on either GRP78 or COX-2 protein expression. Bay 11-7082 suppressed AGE-BSA-induced GRP78 and COX-2 expression. AGE-BSA-induced activation of NF-κB was inhibited by treatment with SB202190 and by eIF2α knockdown, but was not inhibited when chondrocytes were treated with SP600125 or PD98059. CONCLUSION: This study demonstrates that AGEs induce ER stress and stimulate the expression of COX-2 through eIF2α, p38-MAPK and NF-κB pathways in human chondrocytes. Our results provide important insights into cartilage degradation in osteoarthritis associated with latent ER stress.
Authors: Marjan M C Steenvoorden; Tom W J Huizinga; Nicole Verzijl; Ruud A Bank; H Karel Ronday; Hilco A F Luning; Floris P J G Lafeber; René E M Toes; Jeroen DeGroot Journal: Arthritis Rheum Date: 2006-01
Authors: Hao-Yuan Jiang; Sheree A Wek; Barbara C McGrath; Donalyn Scheuner; Randal J Kaufman; Douglas R Cavener; Ronald C Wek Journal: Mol Cell Biol Date: 2003-08 Impact factor: 4.272
Authors: Zafar Rasheed; Arivarasu N Anbazhagan; Nahid Akhtar; Sangeetha Ramamurthy; Frank R Voss; Tariq M Haqqi Journal: Arthritis Res Ther Date: 2009-05-15 Impact factor: 5.156
Authors: Juan Carlos Bermejo-Millo; Marcela Rodrigues Moreira Guimarães; Beatriz de Luxán-Delgado; Yaiza Potes; Zulema Pérez-Martínez; Andrea Díaz-Luis; Beatriz Caballero; Juan José Solano; Ignacio Vega-Naredo; Ana Coto-Montes Journal: Mol Neurobiol Date: 2018-02-28 Impact factor: 5.590
Authors: Ahmed A H Abdellatif; Zafar Rasheed; Ahmad H Alhowail; Abdulmajeed Alqasoumi; Mansour Alsharidah; Riaz A Khan; Abdullah S M Aljohani; Maha A Aldubayan; Waleed Faisal Journal: Int J Nanomedicine Date: 2020-10-30
Authors: Atreju I Lackey; Tina Chen; Yin X Zhou; Natalia M Bottasso Arias; Justine M Doran; Sophia M Zacharisen; Angela M Gajda; William O Jonsson; Betina Córsico; Tracy G Anthony; Laurie B Joseph; Judith Storch Journal: Am J Physiol Gastrointest Liver Physiol Date: 2020-01-06 Impact factor: 4.052